Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
J Antibiot (Tokyo) ; 73(9): 630-635, 2020 09.
Article in English | MEDLINE | ID: mdl-32346089

ABSTRACT

To find a therapeutic alternative for the treatment of skin and soft tissue infections, we evaluated the effects of combinations of retapamulin with macrolide, lincosamide, and streptogramin (MLS) antibiotics against Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecium, and Enterococcus faecalis. Using both the disk diffusion test and checkerboard assay, we initially examined the effects of combinations of retapamulin with MLS antibiotics against standard strains of these species. Combinations of retapamulin with erythromycin, quinupristin/dalfopristin and quinupristin showed synergistic activity against E. faecalis only. Synergy of retapamulin with clindamycin and dalfopristin was not observed. Then, a checkerboard assay was performed to evaluate the effects of the combinations against 15 clinical strains of E. faecalis. Retapamulin and quinupristin, the most synergistic combination, showed activity against all erythromycin-susceptible, -intermediate, and -resistant strains tested. Among the eight strains with high-level erythromycin resistance, five strains were synergistically inhibited in the presence of only 1 µg of retapamulin per ml. Time-kill assay revealed that combinations of retapamulin with erythromycin and quinupristin were bacteriostatic. These results suggest that combinations of retapamulin with erythromycin and quinupristin have in vitro synergistic activity against E. faecalis, including strains with high-level erythromycin resistance.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bridged Bicyclo Compounds, Heterocyclic/therapeutic use , Diterpenes/therapeutic use , Enterococcus faecalis/drug effects , Erythromycin/therapeutic use , Gram-Positive Bacterial Infections/drug therapy , Virginiamycin/analogs & derivatives , Drug Synergism , Enterococcus faecium/drug effects , Humans , Macrolides/therapeutic use , Microbial Sensitivity Tests , Staphylococcus aureus/drug effects , Streptococcus pyogenes/drug effects , Virginiamycin/therapeutic use
2.
Planta Med ; 86(5): 331-337, 2020 Mar.
Article in English | MEDLINE | ID: mdl-32016931

ABSTRACT

Metastasis, which is closely linked to cancer-related deaths, is a highly complex process. It is an organ-specific process and involves interactions between the host and cancer cells. CXC chemokine receptor 4 is known to be expressed in various tumors and the binding with CXC ligand 12 induces signaling in cancer cell survival, migration, and proliferation. Particularly, the CXC chemokine receptor 4/CXC ligand 12 axis is known to promote the metastasis of breast cancer. Thus, agents that can downregulate CXC chemokine receptor 4 expression have potential against cancer metastasis. Minecoside is an active compound extracted from Veronica peregrina L. It is widely distributed in Korea and has been used as a traditional drug for the treatment of various chronic diseases. However, the anticancer and anti-inflammatory effects of minecoside have yet to be clarified. In this study, we found that minecoside downregulates constitutive CXC chemokine receptor 4 expression in MDA-MB-231 breast cancer cells. This downregulation also occurred at the transcriptional level. Minecoside-mediated suppression of CXC chemokine receptor 4 expression inhibited CXC ligand 12-induced invasion of breast and colorectal cancer cells. Overall, our results suggest that minecoside can be a novel anticancer agent that can inhibit cancer metastasis through inhibition of CXC chemokine receptor 4 expression.


Subject(s)
Breast Neoplasms , Colonic Neoplasms , Cell Line, Tumor , Cell Movement , Down-Regulation , Humans , Neoplasm Invasiveness , Receptors, CXCR4
3.
Phytother Res ; 28(12): 1867-72, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25219371

ABSTRACT

In traditional oriental medicine, apricot (Prunus armeniaca L.) seed has been used to treat skin diseases such as furuncle, acne vulgaris and dandruff, as well as coughing, asthma and constipation. This study describes the phytochemical profile and antimicrobial potential of the essential oil obtained from apricot seeds (Armeniacae Semen). The essential oil isolated by hydrodistillation was analysed by gas chromatography-mass spectroscopy. Benzaldehyde (90.6%), mandelonitrile (5.2%) and benzoic acid (4.1%) were identified. Disc diffusion, agar dilution and gaseous contact methods were performed to determine the antimicrobial activity against 16 bacteria and two yeast species. The minimum inhibitory concentrations ranged from 250 to 4000, 500 to 2000 and 250 to 1000 µg/mL for Gram-positive bacteria, Gram-negative bacteria and yeast strains, respectively. The minimum inhibitory doses by gaseous contact ranged from 12.5 to 50, 12.5 to 50 and 3.13 to 12.5 mg/L air for Gram-positive bacteria, Gram-negative bacteria and yeast strains, respectively. The essential oil exhibited a variable degree of antimicrobial activity against a range of bacteria and yeasts tested.


Subject(s)
Anti-Infective Agents/pharmacology , Oils, Volatile/pharmacology , Prunus/chemistry , Seeds/chemistry , Gas Chromatography-Mass Spectrometry , Gram-Negative Bacteria/drug effects , Gram-Positive Bacteria/drug effects , Microbial Sensitivity Tests , Oils, Volatile/chemistry , Plant Oils/chemistry , Plant Oils/pharmacology , Yeasts/drug effects
4.
J Acupunct Meridian Stud ; 4(1): 75-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21440883

ABSTRACT

Extracts of Indonesian medicinal plants, Murraya koenigii, Syzygium polyanthum, and Zingiber purpurea were investigated for their biological activity. The presence of phytochemicals, cytotoxicity, and antimicrobial and antioxidant activities were investigated. Parts of M. koenigii, S. polyanthum, and Z. purpurea were extracted with ethanol. The extracts were evaluated for antimicrobial activity using the disc diffusion method, while antioxidant activity was determined with a 1,1-diphenyl-2-picrylhydrazyl radical scavenging assay. Cytotoxicity was investigated using the brine shrimp lethality test, and phytochemical screening was performed using a standard method. M. koenigii leaf extract exhibited the most activity in the test microorganism activity index (AI), 0.38-1.25, when compared with standard drugs. S. polyanthum ripened fruit displayed significant antioxidant activity (90%) in comparison to ascorbic acid (95%). Z. purpurea rhizome extract possessed the highest cytotoxic effect with a LC(50) of 52 µg/mL. Phytochemical analysis revealed that carbohydrate, tannin, alkaloid, steroid, triterpenoid, and flavonoid were present in the extracts of M. koenigii leaves and twigs, S. polyanthum leaves and ripened and unripe fruits, and Z. purpurea rhizome, while saponin was only present in the S. polyanthum ripened fruit extract. Our work revealed that the M. koenigii leaves, S. polyanthum ripened fruit, and Z. purpurea rhizome extracts have potential as sources of new antimicrobial, antioxidant, and cytotoxic compounds, respectively.


Subject(s)
Anti-Infective Agents/pharmacology , Antioxidants/pharmacology , Cytotoxins/pharmacology , Murraya/chemistry , Plant Extracts/pharmacology , Syzygium/chemistry , Zingiberaceae/chemistry , Animals , Anti-Infective Agents/analysis , Anti-Infective Agents/isolation & purification , Antioxidants/analysis , Antioxidants/isolation & purification , Artemia/drug effects , Ascorbic Acid/pharmacology , Biphenyl Compounds/metabolism , Cytotoxins/analysis , Cytotoxins/isolation & purification , Indonesia , Microbial Sensitivity Tests , Picrates/metabolism , Plant Extracts/chemistry , Plant Structures , Plants, Medicinal
5.
Antimicrob Agents Chemother ; 46(9): 3071-4, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12183275

ABSTRACT

The in vitro and in vivo activities of DW286, a novel fluoronaphthyridone with potent antibacterial activity, were compared with those of ciprofloxacin, gemifloxacin, sparfloxacin, and trovafloxacin. Against gram-positive bacteria, such as Staphylococcus aureus, Staphylococcus epidermidis, Streptococcus pneumoniae, and Enterococcus faecalis, the in vitro activity of DW286 was stronger than that of any other reference antibiotic. Against gram-negative bacteria, the activity of DW286 was similar to those of trovafloxacin and gemifloxacin but was weaker than that of ciprofloxacin. In a mouse systemic infection caused by three S. aureus strains, including methicillin-resistant S. aureus and quinolone-resistant S. aureus (QRSA), DW286 demonstrated the most potent activity, as found in vitro. Specially, DW286 is >or=8-fold more active against QRSA than the other fluoroquinolones. And the 50% protective doses for DW286 were correspondent with the in vitro activities.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Bacterial Infections/drug therapy , Naphthyridines/pharmacology , Animals , Anti-Infective Agents/pharmacology , Anti-Infective Agents/therapeutic use , Bacterial Infections/microbiology , Dogs , Fluoroquinolones , Mice , Microbial Sensitivity Tests , Rats
SELECTION OF CITATIONS
SEARCH DETAIL